Yiqiang Song
Overview
Explore the profile of Yiqiang Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong J, Yang P, Kong D, Song Y, Lu J
Water Res
. 2024 Apr;
255:121546.
PMID: 38574612
Polycyclic aromatic hydrocarbons (PAHs) have become a global environmental concern due to their potential hazardous implication for human health. In this study, we found that sulfate radical (SO) could effectively...
2.
Dedhia P, Chen K, Song Y, Larose E, Imbus J, Peissig P, et al.
Methods Inf Med
. 2022 Jan;
61(1-02):11-18.
PMID: 34991173
Objective: Natural language processing (NLP) systems convert unstructured text into analyzable data. Here, we describe the performance measures of NLP to capture granular details on nodules from thyroid ultrasound (US)...
3.
Shoenbill K, Song Y, Craven M, Johnson H, Smith M, Mendonca E
Prev Med
. 2020 Mar;
136:106061.
PMID: 32179026
Just under half of the 85.7 million US adults with hypertension have uncontrolled blood pressure using a hypertension threshold of systolic pressure ≥ 140 or diastolic pressure ≥ 90. Uncontrolled...
4.
Patterson B, Jacobsohn G, Shah M, Song Y, Maru A, Venkatesh A, et al.
BMC Med Inform Decis Mak
. 2019 Jul;
19(1):138.
PMID: 31331322
Background: Falls among older adults are both a common reason for presentation to the emergency department, and a major source of morbidity and mortality. It is critical to identify fall...
5.
Erbe A, Wang W, Carmichael L, Hoefges A, Grzywacz B, Reville P, et al.
J Immunother Cancer
. 2019 Mar;
7(1):70.
PMID: 30871628
Background: The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy. Clinically-responding patients were randomized...
6.
Shoenbill K, Song Y, Gress L, Johnson H, Smith M, Mendonca E
Health Informatics J
. 2019 Feb;
26(1):388-405.
PMID: 30791802
Lifestyle modification, including diet, exercise, and tobacco cessation, is the first-line treatment of many disorders including hypertension, obesity, and diabetes. Lifestyle modification data are not easily retrieved or used in...
7.
Shoenbill K, Song Y, Cobb N, Drezner M, Mendonca E
J Clin Transl Sci
. 2017 Oct;
1(3):176-183.
PMID: 29082031
Objective: Clinical research involving humans is critically important, but it is a lengthy and expensive process. Most studies require institutional review board (IRB) approval. Our objective is to identify predictors...
8.
Erbe A, Wang W, Carmichael L, Kim K, Mendonca E, Song Y, et al.
Clin Cancer Res
. 2017 Oct;
24(1):189-196.
PMID: 28972044
In 2010, a Children's Oncology Group (COG) phase III randomized trial for patients with high-risk neuroblastoma (ANBL0032) demonstrated improved event-free survival (EFS) and overall survival (OS) following treatment with an...
9.
Erbe A, Wang W, Reville P, Carmichael L, Kim K, Mendonca E, et al.
Front Immunol
. 2017 Jun;
8:675.
PMID: 28659916
Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands....
10.
Erbe A, Wang W, Goldberg J, Gallenberger M, Kim K, Carmichael L, et al.
Clin Cancer Res
. 2016 Oct;
23(9):2159-2168.
PMID: 27742794
Fc-gamma receptors (FCGRs) are expressed on immune cells, bind to antibodies, and trigger antibody-induced cell-mediated antitumor responses when tumor-reactive antibodies are present. The affinity of the FCGR/antibody interaction is variable...